2014

CLAAD Highlights 5 Technologies To Reduce Prescription Drug Abuse

WASHINGTON, Nov. 27, 2012 /PRNewswire-USNewswire/ -- At today's National Prescription Drug Abuse Prevention Policy Consensus Meeting, the not-for-profit Center for Lawful Access and Abuse Deterrence (CLAAD) announced the results of its national contest to identify the "Top 5 Technologies To Reduce Prescription Drug Abuse." 

In alphabetical order, the Top 5 honorees are …

  • Atlantic Pharmaceuticals' SMART/Script dosage form to decrease medication tampering;
  • Eagle Advancement Institute's Clarity program for opioid detoxification, addiction treatment, and aftercare;
  • Egalet's erosion-based drug delivery platform, designed to resist tampering;
  • The Locking Cap, a combination bottle cap to prevent unauthorized access to prescription medications, particularly by children and teens; and
  • Pisgah Labs' P2P Interventions process, designed to safeguard medications' active ingredients.

Honorable mention goes to Abuse Tech's Abuse-Loc, a locking medication bottle to prevent the diversion of drugs from homes.

The Top 5 Technologies competition aims to increase public awareness of the U.S. prescription drug abuse epidemic, and to support private-sector efforts to address the problem.

Michael Barnes, spokesman for CLAAD, stated, "These companies have demonstrated a sincere commitment to reducing prescription drug abuse. We hope the Top 5 Technologies recognition will expedite their success in meeting that goal."

San Diego-based Millennium Laboratories co-sponsored the Top 5 Technologies contest. Millennium provides medication monitoring, drug detection and pharmacogenetic testing services.

"We are proud to recognize the Top 5 honorees joining Millennium in the critically important effort to advance patient care and help address the epidemic of prescription drug abuse," said Howard Appel, President of Millennium Laboratories. 

About the Center for Lawful Access and Abuse Deterrence
The not-for-profit Center for Lawful Access and Abuse Deterrence (CLAAD) is the sponsor of the National Prescription Drug Abuse Prevention Policy Consensus meeting.  In its fifth year, the annual event brings together representatives of government, non-profit health and safety organizations, and industry to identify how best to reduce prescription drug abuse while optimizing patient care.  Follow @claad_coalition.

About Millennium Laboratories
Millennium Laboratories is the leading research-based, clinical diagnostic company dedicated to improving the lives of people with chronic pain and/or addiction. The company provides healthcare professionals with medication monitoring, drug detection and pharmacogenetic testing services to personalize treatment plans to improve clinical outcomes and patient safety. 

SOURCE CLAAD



RELATED LINKS
http://www.claad.org

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.